Development and Evaluation of Fluconazole Co-Crystal for Improved Solubility and Mechanical Properties

被引:0
作者
Rathi, Ritu [1 ]
Singh, Inderbir [1 ]
Sangnim, Tanikan [2 ]
Huanbutta, Kampanart [3 ]
机构
[1] Chitkara Univ, Chitkara Coll Pharm, Rajpura 140401, India
[2] Burapha Univ, Fac Pharmaceut Sci, Saensuk 20131, Mueang Chonburi, Thailand
[3] Rangsit Univ, Coll Pharm, Dept Mfg Pharm, Lak Hok 12000, Mueang Pathum T, Thailand
关键词
co-crystal; antifungal; solubility; tabletability; compaction; compression; COCRYSTAL; PERFORMANCE; DISSOLUTION; ACID;
D O I
10.3390/pharmaceutics17030371
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Fluconazole (FLZ) is a broad-spectrum anti-fungal drug presenting poor flowability, mechanical properties, and limited aqueous solubility. These issues pose challenges for the handling and manufacturing of dosage forms of FLZ. The current research aimed to develop fluconazole co-crystal (CC) for improving its aqueous solubility, flowability, and mechanical properties. (2) Methods: The fluconazole benzoic acid (FLZ-BA) co-crystal was prepared using the solvent evaporation technique. The prepared co-crystal was characterized for drug content, solubility, anti-fungal activity, dissolution, and stability. DSC (Differential Scanning Calorimetry), PXRD (Powder X-Ray Diffraction), SEM (Scanning Electron Microscopy), and FTIR (Fourier Transmission Infrared) spectroscopy were carried out to confirm the co-crystal formation. The co-crystal was further evaluated for their flow characteristics and mechanical properties via CTC (compressibility, tabletability, and compactibility), Heckel, and Kawakita analysis. (3) Results: The CC showed 69.51% drug content and 13-fold greater aqueous solubility than pure FLZ. The DSC thermogram showed a sharp endothermic peak between the parent components, a distinct PXRD pattern was observed, and the SEM analysis revealed a different morphology, confirming the formation of co-crystal (new crystalline form). The CC showed immediate drug release and was found to more stable, and less hygroscopic than FLZ alone. The CC revealed better flowability, tabletability (tensile strength), compressibility, and compactibility. Moreover, Heckel and Kawakita analysis indicated the co-crystal to deform plastically, favoring improved compression. (4) Conclusions: The immediate drug release capabilities, improved hygroscopic stability, solubility, better antifungal activity, and flowability make FLZ-BA co-crystal a suitable candidate for the preparation of an immediate drug release dosage form. The study also revealed the application of co-crystal for improving the flowability and mechanical properties.
引用
收藏
页数:19
相关论文
共 47 条
  • [1] Simultaneously Improving Mechanical, Formulation, and In Vivo Performance of Naproxen by Co-Crystallization
    Abbas, Nasir
    Latif, Sumera
    Afzal, Hafsa
    Arshad, Muhammad Sohail
    Hussain, Amjad
    Sadeeqa, Saleha
    Bukhari, Nadeem Irfan
    [J]. AAPS PHARMSCITECH, 2018, 19 (07): : 3249 - 3257
  • [2] Physicochemical and Anti-fungal Studies of the Pharmaceutical Co-crystal/Salt of Fluconazole
    Ahangar, Aadil A.
    Qadri, Hafsa
    Malik, Asif A.
    Mir, Manzoor Ahmad
    Shah, Abdul Haseeb
    Dar, Aijaz A.
    [J]. MOLECULAR PHARMACEUTICS, 2023, 20 (07) : 3471 - 3483
  • [3] Synthesis, characterization, and stability study of desloratadine multicomponent crystal formation
    Ainurofiq, Ahmad
    Mauludin, Rachmat
    Mudhakir, Diky
    Soewandhi, Sundani Nurono
    [J]. RESEARCH IN PHARMACEUTICAL SCIENCES, 2018, 13 (02) : 93 - 102
  • [4] Fluconazole-tartaric acid co-crystal formation and its mechanical properties
    Alatas, Fikri
    Suwartiningsih, Nia
    Ratih, Hestiary
    Sutarna, Titta Hartyana
    [J]. PHARMACY EDUCATION, 2021, 21 (02): : 116 - 122
  • [5] Structure-mechanics and improved tableting performance of the drug-drug cocrystal metformin:salicylic acid
    Bhatt, Jayshil A.
    Bahl, Dherya
    Morris, Kenneth
    Stevens, Lewis L.
    Haware, Rahul, V
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS, 2020, 153 : 23 - 35
  • [6] Pharmaceutical co-crystals: A green way to enhance drug stability and solubility for improved therapeutic efficacy
    Chettri, Anisha
    Subba, Ankita
    Singh, Govind P.
    Bag, Partha Pratim
    [J]. JOURNAL OF PHARMACY AND PHARMACOLOGY, 2024, 76 (01) : 1 - 12
  • [7] Simultaneously Improving the Mechanical Properties, Dissolution Performance, and Hygroscopicity of Ibuprofen and Flurbiprofen by Cocrystallization with Nicotinamide
    Chow, Shing Fung
    Chen, Miles
    Shi, Limin
    Chow, Albert H. L.
    Sun, Changquan Calvin
    [J]. PHARMACEUTICAL RESEARCH, 2012, 29 (07) : 1854 - 1865
  • [8] Structural investigation and compression of a co-crystal of indomethacin and saccharin
    Connor, Lauren E.
    Vassileiou, Antony D.
    Halbert, Gavin W.
    Johnston, Blair F.
    Oswald, Iain D. H.
    [J]. CRYSTENGCOMM, 2019, 21 (30) : 4465 - 4472
  • [9] Improvement of fluconazole flowability and its effect on dissolution from tablets and capsules
    Consiglieri, Vladi Olga
    Mourao, Samanta
    Sampaio, Mauricio
    Granizo, Patricia
    Garcia, Pedro
    Martinello, Valeska
    Spricigo, Rodrigo
    Ferraz, Humberto Gomes
    [J]. BRAZILIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 46 (01) : 115 - 120
  • [10] Mechanosynthesis, Characterization, and Physicochemical Property Investigation of a Favipiravir Cocrystal with Theophylline and GRAS Coformers
    Deka, Poonam
    Gogoi, Diptajyoti
    Althubeiti, Khaled
    Rao, Dharmaraj R.
    Thakuria, Ranjit
    [J]. CRYSTAL GROWTH & DESIGN, 2021, 21 (08) : 4417 - 4425